The New Billionaires: Younger, Self-Made, More Diverse
Quick, picture a billionaire.
Chances are you conjured up an older, white man who inherited his fortune. That stereotype was pretty accurate for the past century, but times are changing.
Cultural and economic shifts over the past decade are realigning the demographics of the world’s 1 percent, and the billionaires of the future will be self-made, younger, and more diverse, according to a new report from UBS and PwC.
Last year, two-thirds of the world’s billionaires were self-made, compared with just 43 percent of billionaires 20 years ago. The report projects that the trend toward more self-made billionaires will continue get stronger over the next 5 to 10 years, peaking at about 70 percent of the billionaire population.
Related: Playgrounds of the Very Rich and Famous—A 2015 Guide
While two-thirds of current billionaires are over age 60, the average age is getting younger, thanks to both wealth transfers from the older generation and the growth of self-made billionaires.
In addition to getting younger, the report finds that billionaires are also increasingly more diverse. From 2003 to 2013, the number of female billionaires rose from 44 to 116. That’s still less than 10 percent, but it’s a number that’s growing fast.
Part of the trend toward diversity among billionaires is the explosive growth of wealth in Asia. In the first quarter of 2015, China created a new billionaire almost every week. The authors of the report expect that Asia will overtake the United States as the center of billionaire growth in the next decade.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
